Federation des caisses Desjardins du Quebec’s Madrigal Pharmaceuticals MDGL Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$617K	Buy	1,150 +177	+18%	+$90.7K	﹤0.01%	1281
2026 Q1	$509K	Sell	973 -273	-22%	-$130K	﹤0.01%	1253
2025 Q4	$726K	Buy	1,246 +162	+15%	+$82.7K	﹤0.01%	1129
2025 Q3	$497K	Buy	+1,084	New	+$404K	﹤0.01%	1239
2020 Q1	–	Sell	-150	Closed	-$13.7K	–	2307
2019 Q4	$13.7K	Buy	+150	New	+$14.5K	﹤0.01%	1824
2019 Q2	–	Sell	-31	Closed	-$3.88K	–	2305
2019 Q1	$3.88K	Hold	31	–	–	﹤0.01%	1853
2018 Q4	$3.49K	Hold	31	–	–	﹤0.01%	1835
2018 Q3	$6.64K	Hold	31	–	–	﹤0.01%	1824
2018 Q2	$8.67K	Hold	31	–	–	﹤0.01%	1783
2018 Q1	$3.62K	Hold	31	–	–	﹤0.01%	1929
2017 Q4	$2.85K	Hold	31	–	–	﹤0.01%	1956
2017 Q3	$1.39K	Hold	31	–	–	﹤0.01%	1972
2017 Q2	$504	Buy	+31	New	+$485	﹤0.01%	2090

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MDGL Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Madrigal Pharmaceuticals (MDGL) stake by 18% in Q2 2026, buying an estimated $90.7K and bringing the position to 1,150 shares worth $617K. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

Federation des caisses Desjardins du Quebec first reported a position in MDGL in Q2 2017 and has held it in 13 quarters since. The position peaked at $726K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Federation des caisses Desjardins du Quebec held 1,150 shares of Madrigal Pharmaceuticals worth $617K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 177 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $90.7K.
Madrigal Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1281 holding.
Federation des caisses Desjardins du Quebec first reported a position in Madrigal Pharmaceuticals in Q2 2017 and has held it in 13 quarters since.
Federation des caisses Desjardins du Quebec's Madrigal Pharmaceuticals position peaked at $726K in Q4 2025.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.